Epidural abscess

disease
On this page

Also known as extradural intraspinal abscessintraspinal epidural abscessintraspinal extradural abscessspinal epidural abscessspinal epidural abscess (disorder)spinal extradural abscess

Summary

Epidural abscess (MONDO:0005752) is a disease and 2 clinical trials. A subtype of abscess — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameepidural abscess
Mondo IDMONDO:0005752
EFOEFO:0007260
MeSHD020802
DOIDDOID:11387
SNOMED CT61974008
UMLSC0270629
MedGen82848
GARD0024227
Is cancer (heuristic)no

Also known as: extradural intraspinal abscess · intraspinal epidural abscess · intraspinal extradural abscess · spinal epidural abscess · spinal epidural abscess (disorder) · spinal extradural abscess

Disease family

This is a subtype of abscess. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious diseaseabscessepidural abscess

Related subtypes (10): lung abscess, breast abscess, intracranial abscess, corneal abscess, pyoureter, splenic abscess, vitreous abscess, peritonsillar abscess, liver abscess (disease), intersphincteric abscess

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified2

Top trials by phase / activity

NCTPhaseStatusTitle
NCT05464251Not specifiedRECRUITINGProspective Analysis of Spinal Epidural Abscess
NCT06489535Not specifiedCOMPLETEDRetention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.